Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Nutrient control of growth and metabolism through mTORC1 regulation of mRNA splicing.

Takafumi Ogawa | Meltem Isik | Ziyun Wu | Kiran Kurmi | Jin Meng | Sungyun Cho | Gina Lee | L Paulette Fernandez-Cardenas | Masaki Mizunuma | John Blenis | Marcia C Haigis | T Keith Blackwell
Molecular cell | 2024

Cellular growth and organismal development are remarkably complex processes that require the nutrient-responsive kinase mechanistic target of rapamycin complex 1 (mTORC1). Anticipating that important mTORC1 functions remained to be identified, we employed genetic and bioinformatic screening in C. elegans to uncover mechanisms of mTORC1 action. Here, we show that during larval growth, nutrients induce an extensive reprogramming of gene expression and alternative mRNA splicing by acting through mTORC1. mTORC1 regulates mRNA splicing and the production of protein-coding mRNA isoforms largely independently of its target p70 S6 kinase (S6K) by increasing the activity of the serine/arginine-rich (SR) protein RSP-6 (SRSF3/7) and other splicing factors. mTORC1-mediated mRNA splicing regulation is critical for growth; mediates nutrient control of mechanisms that include energy, nucleotide, amino acid, and other metabolic pathways; and may be conserved in humans. Although mTORC1 inhibition delays aging, mTORC1-induced mRNA splicing promotes longevity, suggesting that when mTORC1 is inhibited, enhancement of this splicing might provide additional anti-aging benefits.

Pubmed ID: 39571580

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Monoclonal Anti-GAPDH antibody produced in mouse (antibody)

RRID:AB_1078991

This monoclonal targets GAPDH antibody produced in mouse

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

Phospho-p70 S6 Kinase (Thr389) (108D2) Rabbit mAb (antibody)

RRID:AB_2269803

This monoclonal targets p70 S6 Kinase, phospho (Thr389)

View all literature mentions

N2 (organism)

RRID:WB-STRAIN:WBStrain00000001

Caenorhabditis elegans with name Caenorhabditis elegans wild isolate. from WB.

View all literature mentions

VC597 (organism)

RRID:WB-STRAIN:WBStrain00035906

Caenorhabditis elegans with name rsp-6(ok798) IV/nT1 [qIs51] (IV;V). from WB.

View all literature mentions

VC222 (organism)

RRID:WB-STRAIN:WBStrain00035594

Caenorhabditis elegans with name raga-1(ok386) from WB.

View all literature mentions

621-101 (cell line)

RRID:CVCL_S879

Cell line 621-101 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

RB1206 (organism)

RRID:WB-STRAIN:WBStrain00031907

Caenorhabditis elegans with name rsks-1(ok1255) III. from WB.

View all literature mentions